Ordering from outside the Americas?Switch to the EU store
We don't ship to your country yet. We ship across Europe and the Americas. You can keep browsing.
Account
Research library, mechanism

Mitochondria-linked peptides: MOTS-c and SS-31

MOTS-c is a 16-residue peptide encoded in mitochondrial DNA. SS-31 is a synthetic tetrapeptide designed to target the inner mitochondrial membrane. Both are studied in mitochondrial biology, from different starting points: one is a natural signalling peptide, the other a designed molecule.

Written by the Peptency editorial teamLast reviewed 5 studies checked in PubMed on 5 October 2026

Research-use information. This page summarises published literature and regulator records. It is not guidance for use, not medical advice, and not a statement that any material is suitable for use in people or animals.

What is MOTS-c?

MOTS-c was identified from a short open reading frame in the mitochondrial 12S rRNA gene. A later paper reported that it translocates to the nucleus in response to metabolic stress and regulates nuclear gene expression.[2],[1]

What is SS-31?

SS-31 was designed as a cell-permeable peptide that targets the inner mitochondrial membrane. Mechanism papers report that it interacts with cardiolipin and affects the cytochrome c and cardiolipin complex, electron transport and ATP synthesis. A review covers the development of inner-membrane-targeted peptides.[4],[3],[5]

Which compounds in the catalog belong to this group?

Mitochondria-encoded 16-residue peptideMOTS-c

C101H152N28O22S2, 2174.6 g/mol

Mitochondria-targeted tetrapeptideSS-31

C32H49N9O5, 639.8 g/mol

Research materials: MOTS-c, SS-31.

Which studies are cited on this page?

  1. [1] Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab. 2018;28:516-524.e7.

    Showed that MOTS-c translocates to the nucleus under metabolic stress and regulates nuclear gene expression.

    In vitro and animal studyPMID 29983246DOI 10.1016/j.cmet.2018.06.008

  2. [2] Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, et al.. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21:443-54.

    Identified the MOTS-c open reading frame in mitochondrial DNA and reported its metabolic effects in cells and mice.

    In vitro and animal studyPMID 25738459DOI 10.1016/j.cmet.2015.02.009

  3. [3] Birk AV, Chao WM, Bracken C, Warren JD, Szeto HH. Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol. 2014;171:2017-28.

    Studied SS-31 binding to cardiolipin and its effect on the cytochrome c and cardiolipin complex, electron transport and ATP synthesis.

    Animal studyPMID 24134698DOI 10.1111/bph.12468

  4. [4] Birk AV, Liu S, Soong Y, Mills W, Singh P, Warren JD, et al.. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2013;24:1250-61.

    Studied SS-31 interaction with cardiolipin and ATP recovery in ischaemic mitochondria in a kidney model.

    Animal studyPMID 23813215DOI 10.1681/ASN.2012121216

  5. [5] Szeto HH, Schiller PW. Novel therapies targeting inner mitochondrial membrane: from discovery to clinical development. Pharm Res. 2011;28:2669-79.

    Review of the discovery and development of peptides targeting the inner mitochondrial membrane, including SS-31.

    ReviewPMID 21638136DOI 10.1007/s11095-011-0476-8

Data dates: citations read from PubMed 2026-10-05.